PANRETIN

Marca svizra · 472656 · Marca da pled · En vigur

Inscripziun en il register

Numer da registraziun
472656
Numer da la dumonda
11212/1999
Status
En vigur
Tip
Marca da pled
Deponida
07-12-1999
Registrada
22-05-2000
Publitgada
19-06-2000
Protegida fin ils
07-12-2029
Lingua da la procedura
tudestg
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Pharmazeutische Erzeugnisse und Präparate.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-12-2024

    Adressa dal represchentant midada

    Representative
    WEINMANN ZIMMERLI, Apollostrasse 2, 8032 Zürich → WEINMANN ZIMMERLI, Carmenstrasse 28, 8032 Zürich

    Published in Swissreg on 17.12.2024

  2. 29-02-2024

    Adressa dal possessur midada

    Owner
    Mercury Pharma Group Limited, Capital House, 85 King William Street, London EC4N 7BL, United Kingdom → Mercury Pharma Group Limited, Dashwood House, 69 Old Broad Street, London (EC2M 1QS), United Kingdom

    Published in Swissreg on 29.02.2024

  3. 28-02-2024

    Represchentant stritgà

    Representative
    FMP Fuhrer Marbach & Partner, Konsumstrasse 16A, 3007 Bern (allontanà)

    Published in Swissreg on 28.02.2024

  4. 28-02-2024

    Represchentant inscrit

    Representative
    WEINMANN ZIMMERLI, Apollostrasse 2, 8032 Zürich

    Published in Swissreg on 28.02.2024

  5. 28-08-2020

    Represchentant stritgà

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25 (allontanà)

    Published in Swissreg on 28.08.2020

  6. 28-08-2020

    Transferì

    Owner
    Eisai R&D Management Co., Ltd., 6-10 Koishikawa 4-chome, Bunkyo-ku, Tokyo 112-8088, Japan → Mercury Pharma Group Limited, Capital House, 85 King William Street, London EC4N 7BL, United Kingdom
    Representative
    FMP Fuhrer Marbach & Partner, Konsumstrasse 16A, 3007 Bern

    Published in Swissreg on 28.08.2020

  7. 02-10-2019

    Prolungà

    Published in Swissreg on 02.10.2019

  8. 02-02-2011

    Adressa dal represchentant midada

    Representative
    Bovard AG, Optingenstrasse 16, 3000 Bern 25 → BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 02.02.2011

3 endataziuns pli veglias
  1. 16-09-2009

    Prolungà

    Published in Swissreg on 16.09.2009

  2. 14-09-2009

    Transferì

    Owner
    Ligand Pharmaceuticals Incorporated, 10275 Science Center Drive, San Diego (CA 92121-1117), USA → Eisai R&D Management Co., Ltd., 6-10 Koishikawa 4-chome, Bunkyo-ku, Tokyo 112-8088, Japan
    Representative
    Bovard AG, Patentanwälte, Optingenstrasse 16, 3000 Bern 25 → Bovard AG, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 14.09.2009

  3. 19-06-2000

    Registrà

    Published in the SOGC no. 117 of 19.06.2000

Partidas

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.